SP600125 inhibits cap-dependent translation independently of the c-Jun N-terminal kinase pathway

Cell Struct Funct. 2011;36(1):27-33. doi: 10.1247/csf.10025. Epub 2011 Jan 20.

Abstract

We investigated the effects of SP600125 (formerly called c-Jun N-terminal kinase (JNK) inhibitor II) on translation using cultured mouse cells. SP600125 (50 µM) treatment rapidly repressed overall protein synthesis, accompanied by a reduction in the mRNAs for housekeeping genes such as glyceraldehyde-3-phosphate dehydrogenase in the polysomal fraction. SP600125 decreased polysomes with a concomitant increase in free ribosomal subunits in the cytoplasm, suggesting that global translation was inhibited at the initiation step. A reporter analysis using exogenous mRNAs showed that SP600125 inhibited cap-dependent but not internal ribosome entry site-dependent translation. SP600125 significantly attenuated phosphorylation of components in the mTOR pathway, which is responsible for cap-dependent translation. In contrast to SP600125, short hairpin RNAs for JNK1 and JNK2 failed to affect overall protein synthesis. Collectively, SP600125 inhibits cap-dependent translation, independent of the JNK pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Animals
  • Anthracenes / pharmacology*
  • Gene Knockdown Techniques
  • JNK Mitogen-Activated Protein Kinases / deficiency
  • JNK Mitogen-Activated Protein Kinases / genetics
  • JNK Mitogen-Activated Protein Kinases / metabolism*
  • Mice
  • Protein Biosynthesis / drug effects*
  • Protein Kinase Inhibitors / pharmacology*
  • RNA, Messenger / genetics
  • Signal Transduction / drug effects

Substances

  • Anthracenes
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • pyrazolanthrone
  • JNK Mitogen-Activated Protein Kinases